日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Comprehensive profiling of chromatin occupancy dynamics through the cell cycle

细胞周期中染色质占据动态的全面分析

Li, Yulong; MacAlpine, David M; Hartemink, Alexander J

Genome-wide nucleosome and transcription factor responses to genetic perturbations reveal chromatin-mediated mechanisms of transcriptional regulation

全基因组核小体和转录因子对遗传扰动的响应揭示了染色质介导的转录调控机制。

Moyung, Kevin; Li, Yulong; MacAlpine, Heather K; Hartemink, Alexander J; MacAlpine, David M

Age-structured next generation matrix and R(0) calculation for Mycobacterium avium subsp. paratuberculosis (MAP)

副结核分枝杆菌(MAP)的年龄结构下一代矩阵和R(0)计算

Gao, Yuqi; Hartemink, Nienke; Bijma, Piter; de Jong, Mart C M

Tremelimumab plus Durvalumab prior to Chemoradiotherapy in Unresectable, Locally Advanced Non-Small Cell Lung Cancer: The Induction Trial

在不可切除的局部晚期非小细胞肺癌患者中,化疗放疗前使用曲美利单抗联合度伐利尤单抗:诱导试验

Smeenk, Michiel M; van Diessen, Judi N A; Boellaard, Thierry N; Hartemink, Koen J; de Vries, Jeltje F; van der Noort, Vincent; Badrising, Sushil K; Owers, Emilia C; Monkhorst, Kim; van den Heuvel, Michel M; Theelen, Willemijn S M E

Recurrence prediction using circulating tumor DNA in patients with early-stage non-small cell lung cancer after treatment with curative intent: A retrospective validation study

利用循环肿瘤DNA预测早期非小细胞肺癌根治性治疗后患者的复发:一项回顾性验证研究

Schuurbiers, Milou M F; Smith, Christopher G; Hartemink, Koen J; Rintoul, Robert C; Gale, Davina; Monkhorst, Kim; Mandos, Bas L R; Paterson, Anna L; van den Broek, Daan; Rosenfeld, Nitzan; van den Heuvel, Michel M

Inferring differential protein binding from time-series chromatin accessibility data

从时间序列染色质可及性数据推断差异性蛋白质结合

Mitra, Sneha; Hartemink, Alexander J

Surgical audience focused on multimodality treatment for lung cancer

外科医生们关注肺癌的多模式治疗。

Ogliari, Francesca Rita; Debakker, Sarah; van Zwieten, Tom; Hartemink, Koen J; Willmann, Jonas; Sadowska, Anna M; Hendriks, Lizza

A three dimensional printed endobronchial stent for the treatment of a broncho-esophageal fistula

用于治疗支气管食管瘘的三维打印支气管内支架

Smesseim, Illaa; van Beelen, Sophia; van Dieren, Jolanda M; Hartemink, Koen J; van Sandick, Johanna; Burgers, Jacobus A

Neoadjuvant nivolumab with or without relatlimab in resectable non-small-cell lung cancer: a randomized phase 2 trial

可切除非小细胞肺癌的新辅助治疗中联合或不联合 relatlimab 的 nivolumab 治疗:一项随机 2 期试验

Martin Schuler, Kristof Cuppens, Till Plönes, Marcel Wiesweg, Bert Du Pont, Balazs Hegedus, Johannes Köster, Fabian Mairinger, Kaid Darwiche, Annette Paschen, Brigitte Maes, Michel Vanbockrijck, David Lähnemann, Fang Zhao, Hubertus Hautzel, Dirk Theegarten, Koen Hartemink, Henning Reis, Paul Baas, A

Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial

新辅助阿特珠单抗联合化疗治疗胃癌和胃食管交界处腺癌:PANDA II期试验

Yara L Verschoor ,Joris van de Haar # ,José G van den Berg # ,Johanna W van Sandick ,Liudmila L Kodach ,Jolanda M van Dieren ,Sara Balduzzi ,Cecile Grootscholten ,Marieke E IJsselsteijn ,Alexander A F A Veenhof ,Koen J Hartemink ,Marieke A Vollebergh ,Adham Jurdi ,Shruti Sharma ,Erik Spickard ,Emilia C Owers ,Annemarieke Bartels-Rutten ,Peggy den Hartog ,Noel F C C de Miranda ,Monique E van Leerdam ,John B A G Haanen ,Ton N Schumacher ,Emile E Voest ,Myriam Chalabi